Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06442514 · ClinicalTrials.gov registry record · NA
Pain and Smoking Study - Interactive Voice Response
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT06442514: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT06442514 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06442514, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use Interactive Voice Response (IVR) to optimize the intervention's effectiveness for smoking cessation among Veteran smokers with chronic pain.
Interventions
- OTHER Treatment as Usual
- BEHAVIORAL PASS-IVR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2026-07-13 |
| Est. Completion | 2028-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06442514
The ClinicalTrials.gov registry entry for NCT06442514 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT06442514 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06442514 about?
NCT06442514 is a clinical study titled "Pain and Smoking Study - Interactive Voice Response". PASS2 aims to expand upon the recently completed study (PASS intervention), which tested the telephone delivery of a cognitive behavioral intervention (CBI). This study will use Interactive Voice Response (IVR) to optimize the intervention's effectiveness for smoking cessation among Veteran smokers ...
What is the current status of trial NCT06442514?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2026-07-13. Estimated completion is 2028-05-31.
What interventions are being tested in trial NCT06442514?
The interventions under investigation include: Treatment as Usual (OTHER), PASS-IVR (BEHAVIORAL).
Who is sponsoring clinical trial NCT06442514?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.